{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:42:11Z","timestamp":1780404131366,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Programa de Apoyos para la Superaci\u00f3n del Personal Acad\u00e9mico (PASPA), UNAM"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11064-015-1749-0","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T17:45:44Z","timestamp":1446745544000},"page":"758-769","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na+ and Ca2+ Channels Permeability"],"prefix":"10.1007","volume":"41","author":[{"given":"Mar\u00eda","family":"Sitges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Mar\u00eda","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuron.2004.12.048","volume":"45","author":"D Engel","year":"2005","unstructured":"Engel D, Jonas P (2005) Presynaptic action potential amplification by voltage-gated Na+ channels in hippocampal mossy fiber boutons. Neuron 45:405\u2013417","journal-title":"Neuron"},{"key":"1749_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0920-1211(92)90016-M","volume":"11","author":"S Yamaguchi","year":"1992","unstructured":"Yamaguchi S, Rogawski MA (1992) Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 11:9\u201316","journal-title":"Epilepsy Res"},{"key":"1749_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-1211(03)00031-7","volume":"53","author":"V Nekrassov","year":"2003","unstructured":"Nekrassov V, Sitges M (2003) Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo. Epilepsy Res 53:245\u2013254","journal-title":"Epilepsy Res"},{"key":"1749_CR4","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.clinph.2004.06.019","volume":"115","author":"M Sitges","year":"2004","unstructured":"Sitges M, Nekrassov V (2004) Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin Neurophysiol 115:2711\u20132717","journal-title":"Clin Neurophysiol"},{"key":"1749_CR5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11064-005-8834-8","volume":"30","author":"G Mora","year":"2005","unstructured":"Mora G, Tapia R (2005) Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo. Neurochem Res 30:1557\u20131565","journal-title":"Neurochem Res"},{"key":"1749_CR6","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.clinph.2008.08.009","volume":"119","author":"V Nekrassov","year":"2008","unstructured":"Nekrassov V, Sitges M (2008) Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. Clin Neurophysiol 119:2608\u20132614","journal-title":"Clin Neurophysiol"},{"key":"1749_CR7","doi-asserted-by":"crossref","first-page":"e111665","DOI":"10.1371\/journal.pone.0111665","volume":"9","author":"M Sitges","year":"2014","unstructured":"Sitges M, Gomez CD, Aldana BI (2014) Sertraline reduces IL-1\u03b2 and TNF-\u03b1 mRNA expression and overcomes their rise induced by seizures in the rat hippocampus. PLoS One 9:e111665","journal-title":"PLoS One"},{"key":"1749_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0197-0186(97)00065-X","volume":"32","author":"M Sitges","year":"1998","unstructured":"Sitges M, Pe\u00f1a F, Chiu LM, Guarneros A (1998) Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels. Neurochem Int 32:177\u2013190","journal-title":"Neurochem Int"},{"key":"1749_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuint.2004.07.004","volume":"46","author":"M Sitges","year":"2005","unstructured":"Sitges M, Galindo CA (2005) Omega-agatoxin-TK is a useful tool to study P-type Ca2+ channel-mediated changes in internal Ca2+ and glutamate release in depolarised brain nerve terminals. Neurochem Int 46:53\u201360","journal-title":"Neurochem Int"},{"key":"1749_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145702002997","volume":"5","author":"J Bukanova","year":"2002","unstructured":"Bukanova J, Solntseva E, Skrebitsky V (2002) Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons. Int J Neuropsychopharmacol 5:229\u2013237","journal-title":"Int J Neuropsychopharmacol"},{"key":"1749_CR11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/B:NERE.0000013737.17288.ce","volume":"29","author":"E Galvan","year":"2004","unstructured":"Galvan E, Sitges M (2004) Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem Res 29:347\u2013355","journal-title":"Neurochem Res"},{"key":"1749_CR12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuropharm.2006.09.002","volume":"52","author":"M Sitges","year":"2007","unstructured":"Sitges M, Chiu LM, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52:598\u2013605","journal-title":"Neuropharmacology"},{"key":"1749_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1471-4159.2012.07674.x","volume":"121","author":"BI Aldana","year":"2012","unstructured":"Aldana BI, Sitges M (2012) Sertraline inhibits pre-synaptic Na(+) channel-mediated responses in hippocampus-isolated nerve endings. J Neurochem 121:197\u2013205","journal-title":"J Neurochem"},{"key":"1749_CR14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.yebeh.2003.10.003","volume":"4","author":"F Gilliam","year":"2003","unstructured":"Gilliam F, Hecimovic H, Sheline Y (2003) Psychiatric comorbidity, health and function in epilepsy. Epilepsy Behav 4:S26\u2013S30","journal-title":"Epilepsy Behav"},{"key":"1749_CR15","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/brain\/awn194","volume":"131","author":"A Lothe","year":"2008","unstructured":"Lothe A, Didelot A, Hammers A, Costes M, Saoud M, Gilliam F, Ryvlin P (2008) Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131:2765\u20132782","journal-title":"Brain"},{"key":"1749_CR16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/WCO.0b013e3282f4e978","volume":"21","author":"AM Kanner","year":"2008","unstructured":"Kanner AM (2008) Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 21:190\u2013194","journal-title":"Curr Opin Neurol"},{"key":"1749_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2011.05.023","volume":"233","author":"SC Danzer","year":"2011","unstructured":"Danzer SC (2011) Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233:22\u201332","journal-title":"Exp Neurol"},{"key":"1749_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11940-011-0127-8","volume":"13","author":"KH Noe","year":"2011","unstructured":"Noe KH, Locke DE, Sirven JI (2011) Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 13:371\u2013379","journal-title":"Curr Treat Options Neurol"},{"key":"1749_CR19","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.1528-1167.2011.03133.x","volume":"52","author":"D Stevanovic","year":"2011","unstructured":"Stevanovic D, Jancic J, Lakic A (2011) The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 52:e75\u2013e78","journal-title":"Epilepsia"},{"key":"1749_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yebeh.2012.05.005","volume":"24","author":"H Hecimovic","year":"2012","unstructured":"Hecimovic H, Santos JM, Carter J, Attarian HP, Fessier AJ, Vahle V, Gilliam F (2012) Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav 24:426\u2013429","journal-title":"Epilepsy Behav"},{"key":"1749_CR21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","volume":"24","author":"AM Kanner","year":"2012","unstructured":"Kanner AM, Schachter SC, Barry JJ, Hersdorffer DC, Mula M, Trimble M, Herman B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F (2012) Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 24:156\u2013168","journal-title":"Epilepsy Behav"},{"key":"1749_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrneurol.2012.69","volume":"8","author":"M Mula","year":"2012","unstructured":"Mula M (2012) Epilepsy: bidirectional link between epilepsy and psychiatric disorders. Nat Rev Neurol 8:252\u2013253","journal-title":"Nat Rev Neurol"},{"key":"1749_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.1357749","volume":"258","author":"TJ Turner","year":"1992","unstructured":"Turner TJ, Adams ME, Dunlap K (1992) Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science 258:310\u2013313","journal-title":"Science"},{"key":"1749_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neuropharm.2007.08.016","volume":"53","author":"M Sitges","year":"2007","unstructured":"Sitges M, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 53:854\u2013862","journal-title":"Neuropharmacology"},{"key":"1749_CR25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1471-4159.1989.tb09232.x","volume":"53","author":"GR Tibbs","year":"1989","unstructured":"Tibbs GR, Barrie AP, Van Mieghem FJE, McMahon HT, Nicholls DG (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53:1693\u20131699","journal-title":"J Neurochem"},{"key":"1749_CR26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1471-4159.1991.tb03437.x","volume":"56","author":"FM Heemskerk","year":"1991","unstructured":"Heemskerk FM, Schrama LH, Ghijsen WE, De Graan PN, Lopes da Silva FH, Gispen WH (1991) Presynaptic mechanism of action of 4-aminopyridine: changes in intracellular free Ca2+ concentration and its relationship to B-50 (GAP-43) phosphorylation. J Neurochem 56:1827\u20131835","journal-title":"J Neurochem"},{"key":"1749_CR27","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng M, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"1749_CR28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2007.11.021","volume":"54","author":"RM Kaminski","year":"2008","unstructured":"Kaminski RM, Matagne A, Leclercq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H (2008) SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 54:715\u2013720","journal-title":"Neuropharmacology"},{"key":"1749_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","volume":"43","author":"EA Lukyanetz","year":"2002","unstructured":"Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9\u201318","journal-title":"Epilepsia"},{"key":"1749_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2005.12.019","volume":"49","author":"M Sitges","year":"2006","unstructured":"Sitges M, Chiu LM, Nekrassov V (2006) Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings. Neurochem Int 49:55\u201361","journal-title":"Neurochem Int"},{"key":"1749_CR31","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440\u20133450","journal-title":"J Biol Chem"},{"key":"1749_CR32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1023\/B:NERE.0000018836.82122.23","volume":"29","author":"CA Galindo","year":"2004","unstructured":"Galindo CA, Sitges M (2004) Dihydropiridines mechanism of action in striatal isolated nerve endings: comparison with omega-agatoxin IVA. Neurochem Res 29:659\u2013669","journal-title":"Neurochem Res"},{"key":"1749_CR33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jnr.490400506","volume":"40","author":"M Sitges","year":"1995","unstructured":"Sitges M, Reyes A (1995) Effects of verapamil on the release of different neurotransmitters. J Neurosci Res 40:613\u2013621","journal-title":"J Neurosci Res"},{"key":"1749_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2004.05.005","volume":"60","author":"V Nekrassov","year":"2004","unstructured":"Nekrassov V, Sitges M (2004) Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo. Epilepsy Res 60:63\u201371","journal-title":"Epilepsy Res"},{"key":"1749_CR35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.yebeh.2012.09.005","volume":"25","author":"M Sitges","year":"2012","unstructured":"Sitges M, Aldana BI, Gomez CD, Nekrassov V (2012) The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures. Epilepsy Behav 25:511\u2013516","journal-title":"Epilepsy Behav"},{"key":"1749_CR36","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1097\/00001756-199611250-00048","volume":"7","author":"SJ Wang","year":"1996","unstructured":"Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW (1996) Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport 7:3037\u20133040","journal-title":"Neuroreport"},{"key":"1749_CR37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF00995562","volume":"20","author":"M Sitges","year":"1995","unstructured":"Sitges M, Chiu LM (1995) Characterization of the type of calcium channel primarily regulating GABA exocytosis from brain nerve endings. Neurochem Res 20:1073\u20131080","journal-title":"Neurochem Res"},{"key":"1749_CR38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF00995561","volume":"20","author":"M Sitges","year":"1995","unstructured":"Sitges M, Chiu LM (1995) Omega-Aga IVA selectively inhibits the calcium-dependent fraction of the evoked release of [3H]GABA from synaptosomes. Neurochem Res 20:1065\u20131071","journal-title":"Neurochem Res"},{"key":"1749_CR39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1254\/jphs.08214FP","volume":"108","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K, Nishizawa Y, Sawada K, Ogura H, Miyabe M (2008) K(+)-channel openers suppress epileptiform activities induced by 4-aminopyridine in cultured rat hippocampal neurons. J Pharmacol Sci 108:517\u2013528","journal-title":"J Pharmacol Sci"},{"key":"1749_CR40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W (2002) Basic pharmacology of valproate: a review after 35\u00a0years of clinical use for the treatment of epilepsy. CNS Drugs 16:669\u2013694","journal-title":"CNS Drugs"},{"key":"1749_CR41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1528-1167.2006.01132.x","volume":"48","author":"XF Yang","year":"2007","unstructured":"Yang XF, Weisenfeld A, Rothman SM (2007) Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 48:1861\u20131869","journal-title":"Epilepsia"},{"key":"1749_CR42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2006.09.045","volume":"553","author":"M Guven","year":"2006","unstructured":"Guven M, Bozdemir H, Gunay I, Sarica Y, Kahraman I, Koc F (2006) The actions of lamotrigine and levetiracetam on the conduction properties of isolated rat sciatic nerve. Eur J Pharmacol 553:129\u2013134","journal-title":"Eur J Pharmacol"},{"key":"1749_CR43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/seiz.2000.0504","volume":"10","author":"C Zona","year":"2001","unstructured":"Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG (2001) Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents. Seizure 10:279\u2013286","journal-title":"Seizure"},{"key":"1749_CR44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(99)02348-3","volume":"859","author":"C Bruckner","year":"2000","unstructured":"Bruckner C, Heinemann U (2000) Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res 859:15\u201320","journal-title":"Brain Res"},{"key":"1749_CR45","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1528-1167.2006.00588.x","volume":"47","author":"G D\u2019Arcangelo","year":"2006","unstructured":"D\u2019Arcangelo G, D\u2019Antuono M, Tancredi V, Avoli M (2006) Neocortical hyperexcitability in a genetic model of absence seizures and its reduction by levetiracetam. Epilepsia 47:1144\u20131152","journal-title":"Epilepsia"},{"key":"1749_CR46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1528-1167.2009.02273.x","volume":"51","author":"M D\u2019Antuono","year":"2010","unstructured":"D\u2019Antuono M, Kohling R, Ricalzone S, Gotman J, Biagini G, Avoli M (2010) Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro. Epilepsia 51:423\u2013431","journal-title":"Epilepsia"},{"key":"1749_CR47","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.108.146175","volume":"329","author":"PM Wynne","year":"2009","unstructured":"Wynne PM, Puig SI, Martin GE, Treistman SN (2009) Compartamentalized subunit distribution determines characteristics and ethanol sensitivity of somatic, dendritic and terminal large conductance calcium activate potassium channels in the rat nervous system. J Pharmacol Exp Ther 329:978\u2013986","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"1749_CR48","first-page":"92","volume":"55","author":"M Sitges","year":"2014","unstructured":"Sitges M, Garza-Morales S (2014) Effectiveness of a 12\u00a0h extended release formula of ethyl-apovincaminic acid in the control of seizures in patients with refractory epilepsy. Epilepsia 55(Suppl 2):92\u201393","journal-title":"Epilepsia"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1749-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1749-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1749-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:28:16Z","timestamp":1653474496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1749-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1749-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}